A landmark study which seeks to identify our risk of developing Multiple Sclerosis (MS) and how we might respond to treatment has recruited 2,000 patients and is at the point where it should soon start producing “powerful results”.

Andrea O’Mahony, diagnosed with multiple sclerosis just before her 23rd birthday, is urging anyone with any form of MS to engage in a landmark study that could potentially unlock the mystery of the genetic and lifestyle factors behind the disease.